NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 3 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Recs

1
Player Avatar shekoe (< 20) Submitted: 6/20/2008 8:41:20 AM : Outperform Start Price: $45.79 NUVA Score: -60.75

Makes complete systems for minimally invasive spine fusion surgery. The older we get, the more likely we are to need such surgery. I think the stock is the next Intuitive Surgical (ISRG).

Featured Broker Partners


Advertisement